Industry Under Investigation

June 1, 2001
Jill Wechsler, Pharm Exec's Washington Correspondent

Jill Wechsler is Pharm Exec's Washington Corespondent

Pharmaceutical Executive

Pharmaceutical Executive, Pharmaceutical Executive-06-01-2001, Volume 0, Issue 0

FDA district offices may conduct site investigations to establish baseline information for sampling programs and tracking systems.